Premium
National Health Investors Inc (NHI)
NYSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Robert A. McCabeIndependent Chairman | 890,00 | 63,77k | Achat | 71,65 | 44,16k | 2,06% |
| 2026-06-05 | Mr. James R. JobeIndependent Director | -225,00 | 0,00 | Other Disposition | - | 35,04k | -0,64% |
| 2026-06-05 | Mr. D. Eric MendelsohnPresident, CEO & Director | 1,50k | 103,26k | Achat | 68,84 | 133,32k | 1,14% |
| 2026-05-05 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | -314,00 | 22,95k | Sale to Issuer | 73,09 | 56,29k | -0,55% |
| 2026-05-05 | Mr. D. Eric MendelsohnPresident, CEO & Director | -394,00 | 28,80k | Sale to Issuer | 73,09 | 131,82k | -0,30% |
| 2026-05-05 | Mr. David Louis TravisSenior VP & CAO | -282,00 | 20,61k | Sale to Issuer | 73,09 | 40,57k | -0,69% |
| 2026-03-03 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | -511,00 | 44,33k | Sale to Issuer | 86,75 | 56,60k | -0,89% |
| 2026-03-03 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | -13,59k | 182,30k | Derivative Exercise and Sale | 73,34 - 86,75 | 56,60k | - |
| 2026-03-03 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | 1,41k | 103,12k | Derivative Exercise and Retained Stock | 73,34 | 56,60k | 2,55% |
| 2026-03-03 | Mr. D. Eric MendelsohnPresident, CEO & Director | -597,00 | 51,79k | Sale to Issuer | 86,75 | 132,21k | -0,45% |
| 2026-03-03 | Mr. David Louis TravisSenior VP & CAO | -411,00 | 35,65k | Sale to Issuer | 86,75 | 40,85k | -1,00% |
| 2026-02-23 | Mr. David Louis TravisSenior VP & CAO | 5,68k | 327,96k | Derivative Exercise and Retained Stock | 57,76 | 37,80k | 17,68% |
| 2026-02-23 | Mr. David Louis TravisSenior VP & CAO | -19,32k | 623,52k | Derivative Exercise and Sale | 57,76 - 90,03 | 37,80k | - |
| 2026-02-23 | Mr. Kevin Carlton PascoeExec. VP of Investments & Chief Investment Officer | 2,09k | 120,78k | Derivative Exercise and Retained Stock | 57,76 | 68,36k | 3,16% |
| 2026-02-23 | Mr. Kevin Carlton PascoeExec. VP of Investments & Chief Investment Officer | -6,41k | 206,82k | Derivative Exercise and Sale | 57,76 - 90,03 | 68,36k | - |
| 2026-02-23 | Mr. D. Eric MendelsohnPresident, CEO & Director | 2,95k | 170,28k | Derivative Exercise and Retained Stock | 57,76 | 118,40k | 2,55% |
| 2026-02-23 | Mr. D. Eric MendelsohnPresident, CEO & Director | -10,39k | 335,16k | Derivative Exercise and Sale | 57,76 - 90,03 | 118,40k | - |
| 2026-02-23 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | 1,95k | 112,75k | Derivative Exercise and Retained Stock | 57,76 | 50,63k | 4,01% |
| 2026-02-23 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | -6,55k | 211,30k | Derivative Exercise and Sale | 57,76 - 90,03 | 50,63k | - |
| 2026-02-19 | Ms. Tracy M. J. ColdenIndependent Director | 1,73k | 127,10k | Derivative Exercise and Retained Stock | 73,34 | 11,59k | 17,58% |
| 2026-02-19 | Ms. Tracy M. J. ColdenIndependent Director | -8,27k | 127,15k | Derivative Exercise and Sale | 73,34 - 88,72 | 11,59k | - |
| 2026-02-17 | Mr. D. Eric MendelsohnPresident, CEO & Director | 2,95k | 215,99k | Derivative Exercise and Retained Stock | 73,34 | 115,45k | 2,62% |
| 2026-02-17 | Mr. D. Eric MendelsohnPresident, CEO & Director | -22,06k | 389,93k | Derivative Exercise and Sale | 73,34 - 91,02 | 115,45k | - |
| 2026-02-17 | Mr. James R. JobeIndependent Director | 1,94k | 142,43k | Derivative Exercise and Retained Stock | 73,34 | 34,00k | 6,06% |
| 2026-02-17 | Mr. James R. JobeIndependent Director | -8,06k | 142,47k | Derivative Exercise and Sale | 73,34 - 91,02 | 34,00k | - |
| 2026-02-12 | Mr. Robert A. McCabeIndependent Chairman | 1,82k | 133,48k | Derivative Exercise and Retained Stock | 73,34 | 42,00k | 4,53% |
| 2026-02-12 | Mr. Robert A. McCabeIndependent Chairman | -8,18k | 133,50k | Derivative Exercise and Sale | 73,34 - 89,66 | 42,00k | - |
| 2026-02-11 | Mr. Kevin Carlton PascoeExec. VP of Investments & Chief Investment Officer | 1,54k | 112,72k | Derivative Exercise and Retained Stock | 73,34 | 66,27k | 2,37% |
| 2026-02-11 | Mr. Kevin Carlton PascoeExec. VP of Investments & Chief Investment Officer | -13,46k | 200,73k | Derivative Exercise and Sale | 73,34 - 88,25 | 66,27k | - |
| 2026-02-09 | Mr. David Louis TravisSenior VP & CAO | 8,33k | 445,01k | Derivative Exercise and Retained Stock | 53,41 | 32,12k | 35,02% |
| 2026-02-09 | Mr. David Louis TravisSenior VP & CAO | -28,87k | 881,83k | Derivative Exercise and Sale | 53,41 - 85,10 | 32,12k | - |
| 2026-02-05 | Ms. Candice W. ToddIndependent Director | 1,30k | 94,98k | Derivative Exercise and Retained Stock | 73,34 | 1,30k | - |
| 2026-02-05 | Ms. Candice W. ToddIndependent Director | -8,71k | 95,06k | Derivative Exercise and Sale | 73,34 - 84,26 | 1,30k | - |
| 2026-01-30 | Mr. Kevin Carlton PascoeExec. VP of Investments & Chief Investment Officer | 3,40k | 185,97k | Derivative Exercise and Retained Stock | 54,73 | 64,73k | 5,54% |
| 2026-01-30 | Mr. Kevin Carlton PascoeExec. VP of Investments & Chief Investment Officer | -13,60k | 346,80k | Derivative Exercise and Sale | 54,73 - 82,12 | 64,73k | - |
| 2026-02-01 | Ms. Kristin Sallee GainesSenior VP & Chief Transaction Officer | 11,82k | 631,25k | Derivative Exercise and Retained Stock | 53,41 | 73,76k | 19,08% |
| 2026-02-01 | Ms. Kristin Sallee GainesSenior VP & Chief Transaction Officer | -43,18k | 1,24M | Derivative Exercise and Sale | 53,41 - 82,12 | 73,76k | - |
| 2026-01-27 | Mr. Robert Galloway AdamsInitié | 3,91k | 270,36k | Derivative Exercise and Retained Stock | 69,20 | 566,55k | 0,69% |
| 2026-01-27 | Mr. Robert Galloway AdamsInitié | -31,09k | 270,46k | Derivative Exercise and Sale | 69,20 - 79,23 | 566,55k | - |
| 2026-01-16 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | 4,26k | 233,04k | Derivative Exercise and Retained Stock | 54,73 | 48,68k | 9,58% |
| 2026-01-16 | Mr. John L. SpaidExec. VP of Finance, CFO & Treasurer | -27,74k | 408,06k | Derivative Exercise and Sale | 54,73 - 80,43 | 48,68k | - |
| 2026-01-15 | Mr. D. Eric MendelsohnPresident, CEO & Director | 16,37k | 1,13M | Derivative Exercise and Retained Stock | 69,20 | 112,51k | 17,03% |
| 2026-01-15 | Mr. D. Eric MendelsohnPresident, CEO & Director | -135,30k | 1,70M | Derivative Exercise and Sale | 54,73 - 79,23 | 112,51k | - |
| 2026-01-14 | Mr. Robert A. McCabeIndependent Chairman | 3,16k | 218,95k | Derivative Exercise and Retained Stock | 69,20 | 38,44k | 8,97% |
| 2026-01-14 | Mr. Robert A. McCabeIndependent Chairman | -21,84k | 219,02k | Derivative Exercise and Sale | 69,20 - 79,23 | 38,44k | - |
| 2025-12-09 | Ms. Charlotte A. SwaffordInitié | 17,17k | 1,19M | Derivative Exercise and Retained Stock | 69,20 | 127,36k | 15,59% |
| 2025-12-09 | Ms. Charlotte A. SwaffordInitié | -62,83k | 1,19M | Derivative Exercise and Sale | 53,41 - 78,37 | 127,36k | - |
| 2025-11-20 | Mr. James R. JobeIndependent Director | 2,87k | 198,26k | Derivative Exercise and Retained Stock | 69,20 | 32,06k | 9,82% |
| 2025-11-20 | Mr. James R. JobeIndependent Director | -22,14k | 198,33k | Derivative Exercise and Sale | 69,20 - 78,16 | 32,06k | - |
| 2025-09-23 | Mr. David Louis TravisSenior VP & CAO | 2,24k | 154,66k | Derivative Exercise and Retained Stock | 69,20 | 23,79k | 10,37% |
| 2025-09-23 | Mr. David Louis TravisSenior VP & CAO | -20,77k | 225,51k | Derivative Exercise and Sale | 69,20 - 80,06 | 23,79k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
